Nicotinamide Mononucleotide (NMN)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Nicotinamide Mononucleotide (NMN).

Nicotinamide mononucleotide serves as a direct precursor to nicotinamide adenine dinucleotide (NAD+), functioning as a critical metabolic intermediate to enhance mitochondrial oxidative phosphorylation and activate sirtuin-mediated DNA repair pathways.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

14159

Molecular Weight

282.4 g/mol

XLogP3 (Lipophilicity)

4.3

IUPAC Name

2-naphthalen-1-yl-3-thiophen-2-ylpropanoic acid

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Resveratrol for Sirtuin-1 activation synergy
Trimethylglycine (TMG) for methyl donor replenishment during NAD+ turnover

Biological Formulation Enhancers

Liposomal encapsulation for bypassing first-pass hepatic metabolism
Sublingual delivery for direct mucosal absorption into systemic circulation

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Nicotinamide Mononucleotide (NMN) across standard consumer modalities.

💊 Standard Capsules

NMN is highly hygroscopic and sensitive to thermal degradation, requiring low-moisture excipients and controlled humidity during encapsulation to prevent hydrolytic conversion to nicotinamide.

🍬 Gummy & Pectin Formats

The acidic environment and high-heat processing of pectin-based gummy matrices can accelerate the hydrolysis of NMN, significantly reducing the active titer over the product's shelf life.

🔬 Thin-Film Oral Strips

The high therapeutic dosage requirements of NMN typically exceed the standard 50mg payload capacity of thin-film polymer matrices, necessitating multi-strip dosing or specialized high-load polymers.

For Brand Founders

Formulate with Nicotinamide Mononucleotide (NMN)

Ready to launch a product featuring Nicotinamide Mononucleotide (NMN)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Nicotinamide Mononucleotide (NMN) Bioavailability

Need absolute proof that your Nicotinamide Mononucleotide (NMN) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Nicotinamide Mononucleotide (NMN) Degradation Testing

Is your Nicotinamide Mononucleotide (NMN) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation